Famotidine 20 mg Tablets — Generic For Pepcid — TEVA

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Famotidine tablets are a histamine-2 (H2) receptor antagonist taken by mouth. They are indicated in adult and pediatric patients 40 kg and greater for active duodenal ulcer, active gastric ulcer, symptomatic nonerosive GERD, and erosive esophagitis due to GERD. In adults, they are also indicated for pathological hypersecretory conditions and for reducing the risk of duodenal ulcer recurrence.

The tablet may be taken once daily before bedtime or twice daily in the morning and before bedtime, with or without food. The label says famotidine tablets may be given with antacids. Dose changes are recommended for patients with moderate to severe renal impairment, and the label advises using the lowest effective dose in elderly patients.

Common adverse reactions reported in clinical trials include headache, dizziness, constipation, and diarrhea. The label also warns that serious hypersensitivity reactions can occur, that central nervous system reactions have been reported in elderly patients and patients with renal impairment, and that a response to treatment does not rule out gastric malignancy in adults with certain symptoms or relapse.

Storage Information

STORAGE AND HANDLING Famotidine Tablets USP, 20 mg are available as beige, round, unscored, film-coated tablets, debossed with “5728” on one side and “TEVA” on the other side, containing 20 mg famotidine, packaged in bottles of 100 (NDC 0172-5728-60), 500 (NDC 0172-5728-70) and 1000 (NDC 0172-5728-80) tablets. Dispense in a well-closed, light-resistant container as defined in the USP, with a child-resistant closure (as required). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. storage of famotidine tablets at temperatures above 40°C (104°F).

Key Counseling Points

• Take famotidine tablets exactly as directed on the label or by the prescriber.
• The tablets may be taken with or without food.
• They may be taken once daily before bedtime or twice daily in the morning and before bedtime, as recommended.
• Famotidine tablets may be given with antacids.
• Tell a healthcare professional about all medicines being taken, especially drugs affected by stomach pH or tizanidine, because interactions are listed in the label.
• Use caution if there is a history of serious allergy to famotidine or other H2 receptor antagonists; the label lists this as a contraindication.
• Seek medical advice about new or worsening symptoms, because the label notes that symptom relief does not rule out gastric malignancy in adults.
• Report serious side effects such as confusion, hallucinations, rash, trouble breathing, or swelling as described in the label.
• Common side effects reported in studies include headache, dizziness, constipation, and diarrhea.
• Dosage adjustments are recommended in renal impairment, and the label says elderly patients should use the lowest effective dose and monitor renal function.

Helpful Patient Education

Famotidine tablets are a prescription H2 receptor antagonist used for several acid-related conditions, including duodenal ulcer, gastric ulcer, GERD, erosive esophagitis due to GERD, and certain hypersecretory conditions in adults. The DailyMed label also provides dosing guidance for adult and pediatric patients 40 kg and greater, as well as precautions for renal impairment and older adults.

This product page is educational and based on the label information for famotidine tablets. It includes common adverse reactions, major warnings, and interaction considerations so patients and caregivers can review key safety information from the prescribing label.

Medication Summary last generated: 2026-07-18 02:40:14